Pentwater Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Pentwater Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-199,132	Closed	-$2.04M	–	171
2015 Q2	$2.04M	Sell	199,132 -480,868	-71%	-$5.31M	0.01%	143
2015 Q1	$6.29M	Sell	680,000 -70,000	-9%	-$626K	0.05%	107
2014 Q4	$5.26M	Hold	750,000	–	–	0.04%	106
2014 Q3	$4.09M	Buy	+750,000	New	+$4.31M	0.04%	131

Other funds holding FOMX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Pentwater Capital Management's FOMX Position: Q3 2015 in Review

Pentwater Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2015, closing a stake of 199,132 shares — an estimated $2.04M sold.

Pentwater Capital Management first reported a position in FOMX in Q3 2014 and held it in 4 quarters. The position peaked at $6.29M in Q1 2015. 77 funds tracked by Wall St. Rank hold FOMX as of Q3 2015.

Pentwater Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2015 after selling out during the quarter.
Pentwater Capital Management sold 199,132 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2015, an estimated $2.04M.
Pentwater Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 4 quarters.
Pentwater Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $6.29M in Q1 2015.
77 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2015.

Based on Pentwater Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.